[61Cu]Cu-NODAGA-PSMA-I&T had higher tumor uptake than [18F]PSMA-1007 (10.7 ± 3.3 vs. 6.28 ± 2.19 %IA/g, P = 0.0145) and better tumor-to-blood and tumor-to-nontumor ratios in most cases (Table 3). Here, FOLH1 is linked to neoplasm.